Country President Sandoz Germany & CEO Hexal AG
Salutas Pharma GmbH
Holzkirchen, Bavaria
Thomas Weigold serves as Country President Sandoz Germany & CEO Hexal AG at Salutas Pharma GmbH. Salutas Pharma GmbH operates in the pharmaceuticals sector with approximately 210.0 employees. The company is headquartered in Holzkirchen, Bavaria.
Executives like Thomas Weigold in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Salutas Pharma GmbH.
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated May 2026.
Thomas Weigold's verified email address is available to MessageCEO Pro subscribers. They currently serve as Country President Sandoz Germany & CEO Hexal AG at Salutas Pharma GmbH. Access direct contact info to skip gatekeepers and reach the decision maker.
Thomas Weigold is Country President Sandoz Germany & CEO Hexal AG at Salutas Pharma GmbH, a company in the pharmaceuticals sector with 210.0 employees. The company is based in Holzkirchen, Bavaria.
As Country President Sandoz Germany & CEO Hexal AG at Salutas Pharma GmbH, Thomas Weigold is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Thomas Weigold directly — ideal for B2B sales, partnerships, and executive recruiting.
Thomas Weigold works in the pharmaceuticals industry as Country President Sandoz Germany & CEO Hexal AG at Salutas Pharma GmbH. MessageCEO provides verified contact information for executives across all major industries.
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Thomas Weigold's profile is kept up-to-date with the latest available information.